Compare · TMO vs VELO
TMO vs VELO
Side-by-side comparison of Thermo Fisher Scientific Inc (TMO) and Velo3D Inc. (VELO): market cap, price performance, sector, and recent activity on the wire.
Summary
- TMO operates in Industrials, while VELO operates in Technology - the two are in different parts of the market.
- TMO is the larger of the two at $197.88B, about 627.0x VELO ($315.6M).
- VELO has been more active in the news (11 items in the past 4 weeks vs 9 for TMO).
- TMO has more recent analyst coverage (25 ratings vs 3 for VELO).
- Company
- Thermo Fisher Scientific Inc
- Velo3D Inc.
- Price
- -
- -
- Market cap
- $197.88B
- $315.6M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 9
- 11
- Recent ratings
- 25
- 3
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Velo3D Inc.
Velocity Acquisition Corp. intends to effect a merger, stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in digital transformation businesses. The company was incorporated in 2020 and is based in Ridgefield, Connecticut.
Latest TMO
- Thermo Fisher Scientific Announces Quarterly Dividend
- Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Keith R. Alexandra
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- Bernstein resumed coverage on Thermo Fisher with a new price target
- SEC Form 11-K filed by Thermo Fisher Scientific Inc
- Piper Sandler initiated coverage on Thermo Fisher with a new price target
Latest VELO
- Velo3D Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- Cantor Fitzgerald initiated coverage on Velo3D with a new price target
- Velo3D Expands Strategic Partnership with Mears Machine Corporation as Mears Orders Fifth Sapphire XC to Scale Distributed Manufacturing Across Aviation, Defense, Energy, and Space
- Velo3D Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- SEC Form 4 filed by CEO Jeldi Arun
- Director Krause Stefan exercised 3,188 shares at a strike of $16.64, increasing direct ownership by 31% to 13,410 units (SEC Form 4)
- Director Keppler Adrian exercised 3,188 shares at a strike of $16.64, increasing direct ownership by 32% to 13,248 units (SEC Form 4)
- Director Lloyd Jason Michael exercised 3,188 shares at a strike of $16.64, increasing direct ownership by 28% to 14,375 units (SEC Form 4)
- Velo3D Triples Production Capacity to Meet Strong Defense and Aerospace Demand
- Velo3D Added to Membership of Russell 3000 Index and Russell Microcap Index